Back
Vertex Pharmaceuticals Stock Price Chart
My #1 Coin is...
All the details are on the next page.
Buy
58
VRTX
Vertex Pharmaceuticals
Last Price:
397.43
Seasonality Move:
11.79%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 397.26 | Buy |
| 20-day SMA: | 402.29 | Sell |
| 50-day SMA: | 412.15 | Sell |
| 200-day SMA: | 383.29 | Buy |
| 8-day EMA: | 399.01 | Sell |
| 20-day EMA: | 402.12 | Sell |
| 50-day EMA: | 407.64 | Sell |
| 200-day EMA: | 385.72 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.14 | Sell |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | -107087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (396.36 - 413.98) | Sell |
| Bollinger Bands (100): | (390.37 - 431.87) | Sell |
Vertex Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 397.70 while VRTX 8-day simple moving average is 397.26, which is a Buy signal.
- The stock price of VRTX is 397.70 while Vertex Pharmaceuticals 20-day SMA is 402.29, which makes it a Sell.
- Vertex Pharmaceuticals 50-day simple moving average is 412.15 while VRTX share price is 397.70, making it a Sell technically.
- VRTX stock price is 397.70 and Vertex Pharmaceuticals 200-day simple moving average is 383.29, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $397.70. The Score for VRTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
102.73B
Price in USD:
397.70
Share Volume:
787.23K
Vertex Pharmaceuticals 52-Week Range
52-Week High:
448.40
52-Week Low:
316.43
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 397.70 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 397.70 while VRTX 8-day exponential moving average is 399.01, which is a Sell signal.
- The stock price of VRTX is 397.70 while Vertex Pharmaceuticals 20-day EMA is 402.12, which makes it a Sell.
- Vertex Pharmaceuticals 50-day exponential moving average is 407.64 while VRTX share price is 397.70, making it a Sell technically.
- VRTX stock price is 397.70 and Vertex Pharmaceuticals 200-day simple moving average is 385.72, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.29 per share, an increase this year of $1.64 per share, and an increase next year of $1.39 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -4.14, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 41.98, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (396.36 - 413.98), which suggest Vertex Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (390.37 - 431.87), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.